QuidelOrtho (QDEL) Receivables (2022 - 2026)

QuidelOrtho has disclosed Receivables across 5 years of filings, most recently posting $482.8 million for Q1 2026.

• Receivables for Q1 2026 came in at $482.8 million, up 51.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $482.8 million (up 51.4% YoY), and the FY2025 annual result was $451.7 million, up 8.97% from the prior year.
• Receivables came in at $482.8 million for Q1 2026 at QuidelOrtho, up from $451.7 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $518.6 million in Q3 2025 to a low of $128.7 million in Q3 2022.
• The 5-year median for Receivables is $337.5 million (2023), against an average of $365.1 million.
• Peak annual rise in Receivables reached 151.44% in 2023, while the deepest fall reached 31.46% in 2023.
• QuidelOrtho's Receivables stood at $204.4 million in 2022, then surged by 65.12% to $337.5 million in 2023, then rose by 22.81% to $414.5 million in 2024, then gained by 8.97% to $451.7 million in 2025, then increased by 6.89% to $482.8 million in 2026.
• The last three Receivables figures came in at $482.8 million (Q1 2026), $451.7 million (Q4 2025), and $518.6 million (Q3 2025), per Business Quant data.